Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Scott Grundy

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Risk Factors

Disorders

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
80
Vega, Gloria Lena
21
Jialal, Ishwarlal
19
Garg, Abhimanyu
19
Abate, Nicola
15
Chandalia, Manisha
14
Cohen, Jonathan
11
Devaraj, Sridevi
10
Denke, Margo
10
Mahley, Robert
9
Peshock, Ronald
9
Adams-Huet, Beverley
8
McGuire, Darren
7
Bersot, Thomas
7
Kastelein, John
7
Khera, Amit

Sign-in to see all Coauthors

Publications

TOP 3
Khera Amit; Vega Gloria L; Das Sandeep R; Ayers Colby; McGuire Darren K; Grundy Scott M; de Lemos James A
Sex differences in the relationship between C-reactive protein and body fat.
Grundy Scott M; Vega Gloria Lena; Tomassini Joanne E; Tershakovec Andrew M
Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
Shah Meena; Chandalia Manisha; Adams-Huet Beverley; Brinkley Linda J; Sakhaee Khashayar; Grundy Scott M; Garg Abhimanyu
Effect of a high-fiber diet compared with a moderate-fiber diet on calcium and other mineral balances in subjects with type 2 diabetes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Scott Grundy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Khera Amit; Vega Gloria L; Das Sandeep R; Ayers Colby; McGuire Darren K; Grundy Scott M; de Lemos James A
Sex differences in the relationship between C-reactive protein and body fat.
The Journal of clinical endocrinology and metabolism 2009;94(9):3251-8.
2009: Grundy Scott M; Vega Gloria Lena; Tomassini Joanne E; Tershakovec Andrew M
Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
The American journal of cardiology 2009;104(4):548-53.
2009: Shah Meena; Chandalia Manisha; Adams-Huet Beverley; Brinkley Linda J; Sakhaee Khashayar; Grundy Scott M; Garg Abhimanyu
Effect of a high-fiber diet compared with a moderate-fiber diet on calcium and other mineral balances in subjects with type 2 diabetes.
Diabetes care 2009;32(6):990-5.
2009: Vega Gloria Lena; Dunn Fredrick L; Grundy Scott M
Impaired hepatic ketogenesis in moderately obese men with hypertriglyceridemia.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2009;57(4):590-4.
2008: Johnson Colleen; Waters David D; DeMicco David A; Breazna Andrei; Bittner Vera; Greten Heiner; Grundy Scott M; LaRosa John C
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study).
The American journal of cardiology 2008;102(10):1312-7.
2008: Vega Gloria Lena; Clarenbach Jacob J; Dunn Fredrick; Grundy Scott M
Oxandrolone enhances hepatic ketogenesis in adult men.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2008;56(7):920-4.
2008: Chen Karen; Lindsey Jason B; Khera Amit; De Lemos James A; Ayers Colby R; Goyal Abhinav; Vega Gloria L; Murphy Sabina A; Grundy Scott M; McGuire Darren K
Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(2):96-101.
2008: Vega Gloria Lena; Chandalia Manisha; Szczepaniak Lidia S; Grundy Scott M
Effects of N-3 fatty acids on hepatic triglyceride content in humans.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2008;56(5):780-5.
2008: Kastelein John J P; van der Steeg Wim A; Holme Ingar; Gaffney Michael; Cater Nilo B; Barter Philip; Deedwania Prakash; Olsson Anders G; Boekholdt S Matthijs; Demicco David A; Szarek Michael; LaRosa John C; Pedersen Terje R; Grundy Scott M;
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
Circulation 2008;117(23):3002-9.
2008: See Raphael; Lindsey Jason B; Patel Mahesh J; Ayers Colby R; Khera Amit; McGuire Darren K; Grundy Scott M; de Lemos James A
Application of the screening for Heart Attack Prevention and Education Task Force recommendations to an urban population: observations from the Dallas Heart Study.
Archives of internal medicine 2008;168(10):1055-62.
2008: Grundy Scott M
Metabolic syndrome pandemic.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(4):629-36.
2008: Sandhu Manjinder S; Waterworth Dawn M; Debenham Sally L; Wheeler Eleanor; Papadakis Konstantinos; Zhao Jing Hua; Song Kijoung; Yuan Xin; Johnson Toby; Ashford Sofie; Inouye Michael; Luben Robert; Sims Matthew; Hadley David; McArdle Wendy; Barter Philip; Kesäniemi Y Antero; Mahley Robert W; McPherson Ruth; Grundy Scott M; Bingham Sheila A; Khaw Kay-Tee; Loos Ruth J F; Waeber Gérard; Barroso Inês; Strachan David P; Deloukas Panagiotis; Vollenweider Peter; Wareham Nicholas J; Mooser Vincent
LDL-cholesterol concentrations: a genome-wide association study.
Lancet 2008;371(9611):483-91.
2008: Grundy Scott M
Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention.
Circulation 2008;117(4):569-73; discussion 573.
2008: Grundy Scott M
Thyroid mimetic as an option for lowering low-density lipoprotein.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(2):409-10.
2008: Grundy Scott M; Adams-Huet Beverley; Vega Gloria Lena
Variable contributions of fat content and distribution to metabolic syndrome risk factors.
Metabolic syndrome and related disorders 2008;6(4):281-8.
2007: Shah Meena; Adams-Huet Beverley; Brinkley Linda; Grundy Scott M; Garg Abhimanyu
Lipid, glycemic, and insulin responses to meals rich in saturated, cis-monounsaturated, and polyunsaturated (n-3 and n-6) fatty acids in subjects with type 2 diabetes.
Diabetes care 2007;30(12):2993-8.
2007: Abdullah Shuaib M; Khera Amit; Leonard David; Das Sandeep R; Canham Russell M; Kamath Sandeep A; Vega Gloria L; Grundy Scott M; McGuire Darren K; de Lemos James A
Sex differences in the association between leptin and CRP: results from the Dallas Heart Study.
Atherosclerosis 2007;195(2):404-10.
2007: Barter Philip J; Caulfield Mark; Eriksson Mats; Grundy Scott M; Kastelein John J P; Komajda Michel; Lopez-Sendon Jose; Mosca Lori; Tardif Jean-Claude; Waters David D; Shear Charles L; Revkin James H; Buhr Kevin A; Fisher Marian R; Tall Alan R; Brewer Bryan;
Effects of torcetrapib in patients at high risk for coronary events.
The New England journal of medicine 2007;357(21):2109-22.
2007: Barter Philip; Gotto Antonio M; LaRosa John C; Maroni Jaman; Szarek Michael; Grundy Scott M; Kastelein John J P; Bittner Vera; Fruchart Jean-Charles;
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
The New England journal of medicine 2007;357(13):1301-10.
2007: Grundy Scott M
Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?
The American journal of medicine 2007;120(9 Suppl 1):S3-8; discussion S9.
2007: LaRosa John C; Grundy Scott M; Kastelein John J P; Kostis John B; Greten Heiner;
Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
The American journal of cardiology 2007;100(5):747-52.
2007: Vega Gloria Lena; Chandalia Manisha; Szczepaniak Lidia S; Grundy Scott M
Metabolic correlates of nonalcoholic fatty liver in women and men.
Hepatology (Baltimore, Md.) 2007;46(3):716-22.
2007: See Raphael; Abdullah Shuaib M; McGuire Darren K; Khera Amit; Patel Mahesh J; Lindsey Jason B; Grundy Scott M; de Lemos James A
The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study.
Journal of the American College of Cardiology 2007;50(8):752-9.
2007: Barter Philip; McPherson Y Ruth; Song Kijoung; Kesäniemi Y Antero; Mahley Robert; Waeber Gérard; Bersot Thomas; Mooser Vincent; Waterworth Dawn; Grundy Scott M
Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia.
The Journal of clinical endocrinology and metabolism 2007;92(6):2041-5.
2007: Grundy Scott M
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes.
BMJ (Clinical research ed.) 2007;334(7601):982.
2007: Chandalia Manisha; Grundy Scott M; Adams-Huet Beverley; Abate Nicola
Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort.
Journal of diabetes and its complications 2007;21(3):143-8.
2007: Assmann Gerd; Guerra Rudy; Fox Garrett; Cullen Paul; Schulte Helmut; Willett DuWayne; Grundy Scott M
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations.
The American journal of cardiology 2007;99(4):541-8.
2007: Grundy Scott M
Metabolic syndrome: a multiplex cardiovascular risk factor.
The Journal of clinical endocrinology and metabolism 2007;92(2):399-404.
2007: Chang Craig; Garcia-Garcia Ana-Barbara; Hamilton Elizabeth; Shah Brijen; Meguro Shinichi; Grundy Scott M; Provost David; Vega Gloria Lena
Metabolic syndrome phenotype in very obese women.
Metabolic syndrome and related disorders 2007;5(1):3-12.
2007: Chandalia Manisha; Lin Ping; Seenivasan Thanalakshmi; Livingston Edward H; Snell Peter G; Grundy Scott M; Abate Nicola
Insulin resistance and body fat distribution in South Asian men compared to Caucasian men.
PloS one 2007;2(8):e812.
2006: Abate Nicola; Chandalia Manisha; Di Paola Rosa; Foster Daniel W; Grundy Scott M; Trischitta Vincenzo
Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Nature clinical practice. Endocrinology & metabolism 2006;2(12):694-701.
2006: Waters David D; LaRosa John C; Barter Philip; Fruchart Jean-Charles; Gotto Antonio M; Carter Roddy; Breazna Andrei; Kastelein John J P; Grundy Scott M
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.
Journal of the American College of Cardiology 2006;48(9):1793-9.
2006: Vega Gloria Lena; Adams-Huet Beverley; Peshock Ron; Willett Duwayne; Shah Brijen; Grundy Scott M
Influence of body fat content and distribution on variation in metabolic risk.
The Journal of clinical endocrinology and metabolism 2006;91(11):4459-66.
2006: Deedwania Prakash; Barter Philip; Carmena Rafael; Fruchart Jean-Charles; Grundy Scott M; Haffner Steven; Kastelein John J P; LaRosa John C; Schachner Holly; Shepherd James; Waters David D;
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Lancet 2006;368(9539):919-28.
2006: Grundy Scott M
Does the metabolic syndrome exist?
Diabetes care 2006;29(7):1689-92; discussion 1693-6.
2006: Grundy Scott M
Does a diagnosis of metabolic syndrome have value in clinical practice?
The American journal of clinical nutrition 2006;83(6):1248-51.
2006: Radha Venkatesan; Vimaleswaran Karani S; Babu Hunsur Narayan S; Abate Nicola; Chandalia Manisha; Satija Pankaj; Grundy Scott M; Ghosh Saurabh; Majumder Partha P; Deepa Raj; Rao Sathyanarayana M R; Mohan Viswanathan
Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.
Diabetes care 2006;29(5):1046-51.
2006: Grundy Scott M
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.
Nature reviews. Drug discovery 2006;5(4):295-309.
2006: Grundy Scott M
Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
Journal of the American College of Cardiology 2006;47(6):1093-100.
2006: Cohen Jonathan C; Pertsemlidis Alexander; Fahmi Saleemah; Esmail Sophie; Vega Gloria L; Grundy Scott M; Hobbs Helen H
Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(6):1810-5.
2006: Khera Amit; de Lemos James A; Peshock Ronald M; Lo Hao S; Stanek Harold G; Murphy Sabina A; Wians Frank H; Grundy Scott M; McGuire Darren K
Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.
Circulation 2006;113(1):38-43.
2006: Grundy Scott M
Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance.
Clinical cornerstone 2006;8 Suppl 1():S21-7.
2005: Yu Yi; Wyszynski Diego F; Waterworth Dawn M; Wilton Steven D; Barter Philip J; Kesäniemi Y Antero; Mahley Robert W; McPherson Ruth; Waeber Gérard; Bersot Thomas P; Ma Qianli; Sharma Sanjay S; Montgomery Douglas S; Middleton Lefkos T; Sundseth Scott S; Mooser Vincent; Grundy Scott M; Farrer Lindsay A
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.
Journal of lipid research 2005;46(10):2202-13.
2005: Khera Amit; McGuire Darren K; Murphy Sabina A; Stanek Harold G; Das Sandeep R; Vongpatanasin Wanpen; Wians Frank H; Grundy Scott M; de Lemos James A
Race and gender differences in C-reactive protein levels.
Journal of the American College of Cardiology 2005;46(3):464-9.
2005: Grundy Scott M
Point: the metabolic syndrome still lives.
Clinical chemistry 2005;51(8):1352-4.
2005: Grundy Scott M
Stanol esters as a component of maximal dietary therapy in the National Cholesterol Education Program Adult Treatment Panel III report.
The American journal of cardiology 2005;96(1A):47D-50D.
2005: Cater Nilo B; Garcia-Garcia Ana-Barbara; Vega Gloria Lena; Grundy Scott M
Responsiveness of plasma lipids and lipoproteins to plant stanol esters.
The American journal of cardiology 2005;96(1A):23D-28D.
2005: Vega Gloria Lena; Cater Nilo B; Meguro Shinishi; Grundy Scott M
Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia.
The American journal of cardiology 2005;95(11):1309-13.
2005: Abate Nicola; Chandalia Manisha; Satija Pankaj; Adams-Huet Beverley; Grundy Scott M; Sandeep Sreedharan; Radha Venkatesan; Deepa Raj; Mohan Viswanathan
ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes.
Diabetes 2005;54(4):1207-13.
2005: LaRosa John C; Grundy Scott M; Waters David D; Shear Charles; Barter Philip; Fruchart Jean-Charles; Gotto Antonio M; Greten Heiner; Kastelein John J P; Shepherd James; Wenger Nanette K;
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
The New England journal of medicine 2005;352(14):1425-35.
2005: Wyszynski Diego F; Waterworth Dawn M; Barter Philip J; Cohen Jonathan; Kesäniemi Y Antero; Mahley Robert W; McPherson Ruth; Waeber Gérard; Bersot Thomas P; Sharma Sanjay S; Nolan Vikki; Middleton Lefkos T; Sundseth Scott S; Farrer Lindsay A; Mooser Vincent; Grundy Scott M
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).
The American journal of cardiology 2005;95(2):194-8.
2005: Grundy S M
Metabolic syndrome: therapeutic considerations.
Handbook of experimental pharmacology 2005;(170):107-33.
2005: Grundy Scott M
A constellation of complications: the metabolic syndrome.
Clinical cornerstone 2005;7(2-3):36-45.
2004: Browning Jeffrey D; Szczepaniak Lidia S; Dobbins Robert; Nuremberg Pamela; Horton Jay D; Cohen Jonathan C; Grundy Scott M; Hobbs Helen H
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
Hepatology (Baltimore, Md.) 2004;40(6):1387-95.
2004: Wilund Kenneth R; Yu Liqing; Xu Fang; Vega Gloria L; Grundy Scott M; Cohen Jonathan C; Hobbs Helen H
No association between plasma levels of plant sterols and atherosclerosis in mice and men.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(12):2326-32.
2004: Jain Tulika; Peshock Ronald; McGuire Darren K; Willett DuWayne; Yu Zhoaxia; Vega Gloria L; Guerra Rudy; Hobbs Helen H; Grundy Scott M;
African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study.
Journal of the American College of Cardiology 2004;44(5):1011-7.
2004: Grundy Scott M
Metabolic syndrome: part II.
Endocrinology and metabolism clinics of North America 2004;33(3):xi-xiii.
2004: Abate Nicola; Chandalia Manisha; Snell Peter G; Grundy Scott M
Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men.
The Journal of clinical endocrinology and metabolism 2004;89(6):2750-5.
2004: Grundy Scott M
Obesity, metabolic syndrome, and cardiovascular disease.
The Journal of clinical endocrinology and metabolism 2004;89(6):2595-600.
2004: Grundy Scott M
Metabolic syndrome: part I.
Endocrinology and metabolism clinics of North America 2004;33(2):ix-xi.
2004: Grundy Scott M
What is the contribution of obesity to the metabolic syndrome?
Endocrinology and metabolism clinics of North America 2004;33(2):267-82, table of contents.
2003: Abate Nicola; Carulli Lucia; Cabo-Chan Alberto; Chandalia Manisha; Snell Peter G; Grundy Scott M
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance.
The Journal of clinical endocrinology and metabolism 2003;88(12):5927-34.
2003: Grundy Scott M
Atherosclerosis imaging for risk assessment and primary prevention of cardiovascular disease.
Progress in cardiovascular diseases 2003;46(2):115-21.
2003: Vega Gloria Lena; Cater Nilo B; Hadizadeh Dariusch R; Meguro Shinichi; Grundy Scott M
Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Clinical pharmacology and therapeutics 2003;74(3):236-44.
2003: Chandalia Manisha; Cabo-Chan Alberto V; Devaraj Sridevi; Jialal Ishwarlal; Grundy Scott M; Abate Nicola
Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States.
The Journal of clinical endocrinology and metabolism 2003;88(8):3773-6.
2003: Vega Gloria Lena; Ma Patrick T S; Cater Nilo B; Filipchuk Neil; Meguro Shinichi; Garcia-Garcia Ana Barbara; Grundy Scott M
Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
The American journal of cardiology 2003;91(8):956-60.
2003: Chandalia Manisha; Abate Nicola; Cabo-Chan Alberto V; Devaraj Sridevi; Jialal Ishwarlal; Grundy Scott M
Hyperhomocysteinemia in Asian Indians living in the United States.
The Journal of clinical endocrinology and metabolism 2003;88(3):1089-95.
2002: Grundy Scott M; Abate Nicola; Chandalia Manisha
Diet composition and the metabolic syndrome: what is the optimal fat intake?
The American journal of medicine 2002;113 Suppl 9B():25S-29S.
2002: Mathur Surekha; Devaraj Sridevi; Grundy Scott M; Jialal Ishwarlal
Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans.
The Journal of nutrition 2002;132(12):3663-7.
2002: O'Byrne Dawn J; Devaraj Sridevi; Grundy Scott M; Jialal Ishwarlal
Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults.
The American journal of clinical nutrition 2002;76(6):1367-74.
2002: Grundy Scott M
Alternative approaches to cholesterol-lowering therapy.
The American journal of cardiology 2002;90(10):1135-8.
2002: Grundy Scott M;
Approach to lipoprotein management in 2001 National Cholesterol Guidelines.
The American journal of cardiology 2002;90(8A):11i-21i.
2002: Abate Nicola; Haffner Steven M; Garg Abhimanyu; Peshock Ronald M; Grundy Scott M
Sex steroid hormones, upper body obesity, and insulin resistance.
The Journal of clinical endocrinology and metabolism 2002;87(10):4522-7.
2002: Grundy Scott M; Vega Gloria Lena; McGovern Mark E; Tulloch Brian R; Kendall David M; Fitz-Patrick David; Ganda Om P; Rosenson Robert S; Buse John B; Robertson David D; Sheehan John P;
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
Archives of internal medicine 2002;162(14):1568-76.
2002: Shohet Ralph V; Vega Gloria L; Bersot Thomas P; Mahley Robert W; Grundy Scott M; Guerra Rudy; Cohen Jonathan C
Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC).
Human mutation 2002;19(5):536-42.
2002: Berge Knut E; von Bergmann Klaus; Lutjohann Dieter; Guerra Rudy; Grundy Scott M; Hobbs Helen H; Cohen Jonathan C
Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8.
Journal of lipid research 2002;43(3):486-94.
2001: Grundy S M
United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy.
The American journal of cardiology 2001;88(7B):23J-27J.
2001: Grundy S M
Coronary plaque as a replacement for age as a risk factor in global risk assessment.
The American journal of cardiology 2001;88(2A):8E-11E.
2001: Grundy S M; D'Agostino Sr R B; Mosca L; Burke G L; Wilson P W; Rader D J; Cleeman J I; Roccella E J; Cutler J A; Friedman L M
Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop.
Circulation 2001;104(4):491-6.
2001: Meira L B; Devaraj S; Kisby G E; Burns D K; Daniel R L; Hammer R E; Grundy S; Jialal I; Friedberg E C
Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress.
Cancer research 2001;61(14):5552-7.
2001: Kaul N; Devaraj S; Grundy S M; Jialal I
Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects.
The American journal of cardiology 2001;87(11):1320-3.
2001: Jialal I; Stein D; Balis D; Grundy S M; Adams-Huet B; Devaraj S
Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.
Circulation 2001;103(15):1933-5.
2001: O'Byrne D; Devaraj S; Islam K N; Collazo R; McDonald L; Grundy S; Jialal I
Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
Metabolism: clinical and experimental 2001;50(2):207-15.
2000: O'Byrne D; Grundy S; Packer L; Devaraj S; Baldenius K; Hoppe P P; Kraemer K; Jialal I; Traber M G
Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans.
Free radical biology & medicine 2000;29(9):834-45.
2000: Chandalia M; Garg A; Lutjohann D; von Bergmann K; Grundy S M; Brinkley L J
Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.
The New England journal of medicine 2000;342(19):1392-8.
2000: Islam K N; O'Byrne D; Devaraj S; Palmer B; Grundy S M; Jialal I
Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
Atherosclerosis 2000;150(1):217-24.
2000: Grundy S M
Cholesterol management in the era of managed care.
The American journal of cardiology 2000;85(3A):3A-9A.
2000: Toto R D; Grundy S M; Vega G L
Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome.
American journal of nephrology 2000;20(1):12-7.
1999: Grundy S M
Primary prevention of coronary heart disease: selection of patients for aggressive cholesterol management.
The American journal of medicine 1999;107(2A):2S-6S.
1999: Grundy S M
Primary prevention of coronary heart disease: integrating risk assessment with intervention.
Circulation 1999;100(9):988-98.
1999: Shohet R V; Vega G L; Anwar A; Cigarroa J E; Grundy S M; Cohen J C
Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(8):1975-8.
1999: Vega G L; von Bergmann K; Grundy S M; Blumenschein S; Carter N B; Laeis P; Lindenthal B; von Bergmann J; Simatupang A; Lutjohann D; Adams-Huet B
Effect of lifibrol on the metabolism of low density lipoproteins and cholesterol.
Journal of internal medicine 1999;246(1):1-9.
1999: Chandalia M; Abate N; Garg A; Stray-Gundersen J; Grundy S M
Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men.
The Journal of clinical endocrinology and metabolism 1999;84(7):2329-35.
1999: Grundy S M
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.
The American journal of cardiology 1999;83(9B):25F-29F.
1999: Bersot T P; Vega G L; Grundy S M; Palaoglu K E; Atagündüz P; Ozbayrakçi S; Gökdemir O; Mahley R W
Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population.
Journal of lipid research 1999;40(3):432-8.
1999: Grundy S M; Vega G L; Otvos J D; Rainwater D L; Cohen J C
Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence.
Journal of lipid research 1999;40(2):229-34.
1998: Grundy S M
Cholesterol management in high-risk patients without heart disease. When is lipid-lowering medication warranted for primary prevention?
Postgraduate medicine 1998;104(5):117-20, 123-4, 129.
1998: Grundy S M
The role of cholesterol management in coronary disease risk reduction in elderly patients.
Endocrinology and metabolism clinics of North America 1998;27(3):655-75, x.
1998: Nie L; Niu S; Vega G L; Clark L T; Tang A; Grundy S M; Cohen J C
Three polymorphisms associated with low hepatic lipase activity are common in African Americans.
Journal of lipid research 1998;39(9):1900-3.
1998: Patel S B; Salen G; Hidaka H; Kwiterovich P O; Stalenhoef A F; Miettinen T A; Grundy S M; Lee M H; Rubenstein J S; Polymeropoulos M H; Brownstein M J
Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21.
The Journal of clinical investigation 1998;102(5):1041-4.
1998: Vega G L; Gao J; Bersot T P; Mahley R W; Verstraete R; Grundy S M; White A; Cohen J C
The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity.
Journal of lipid research 1998;39(7):1520-4.
1998: Devaraj S; Vega G; Lange R; Grundy S M; Jialal I
Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease.
The American journal of medicine 1998;104(5):445-50.
1998: Nie L; Wang J; Clark L T; Tang A; Vega G L; Grundy S M; Cohen J C
Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity.
Journal of lipid research 1998;39(5):1127-30.
1998: Mostaza J M; Vega G L; Snell P; Grundy S M
Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue.
Journal of internal medicine 1998;243(4):265-74.
1998: Tatò F; Vega G L; Grundy S M
Effects of crystalline nicotinic acid-induced hepatic dysfunction on serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase.
The American journal of cardiology 1998;81(6):805-7.
1998: Grundy S M
Multifactorial causation of obesity: implications for prevention.
The American journal of clinical nutrition 1998;67(3 Suppl):563S-72S.
1998: Vega G L; Grundy S M
Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.
The American journal of cardiology 1998;81(4A):36B-42B.
1998: Grundy S M
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
The American journal of cardiology 1998;81(4A):18B-25B.
1998: Grundy S M
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
The American journal of cardiology 1998;81(4A):1B-6B.
1998: Vega G L; Clark L T; Tang A; Marcovina S; Grundy S M; Cohen J C
Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC).
Journal of lipid research 1998;39(1):228-32.
1997: Grundy S M
What is the desirable ratio of saturated, polyunsaturated, and monounsaturated fatty acids in the diet?
The American journal of clinical nutrition 1997;66(4 Suppl):988S-990S.
1997: Nemeth-Slany A; Talmud P; Grundy S M; Patel S B
Activation of a cryptic splice-site in intron 24 leads to the formation of apolipoprotein B-27.6.
Atherosclerosis 1997;133(2):163-70.
1997: Grundy S M
Cholesterol management in patients with heart disease. Emphasizing secondary prevention to increase longevity.
Postgraduate medicine 1997;102(2):81-4, 87-90.
1997: Li X; Grundy S M; Patel S B
Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100.
Journal of lipid research 1997;38(7):1277-88.
1997: Grundy S M
Cholesterol and coronary heart disease. The 21st century.
Archives of internal medicine 1997;157(11):1177-84.
1997: Mostaza J M; Schulz I; Vega G L; Grundy S M
Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia.
The American journal of cardiology 1997;79(9):1298-301.
1997: Grundy S M
Primary prevention of coronary heart disease: role of cholesterol control in the United States.
Journal of internal medicine 1997;241(4):295-306.
1997: Grundy S M
Cholesterol issues as viewed from the United States.
Journal of internal medicine 1997;241(4):279-81.
1997: Guerra R; Wang J; Grundy S M; Cohen J C
A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(9):4532-7.
1997: Misra A; Garg A; Abate N; Peshock R M; Stray-Gundersen J; Grundy S M
Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men.
Obesity research 1997;5(2):93-9.
1997: Grundy S M
Management of high serum cholesterol and related disorders in patients at risk for coronary heart disease.
The American journal of medicine 1997;102(2A):15-22.
1997: Abate N; Garg A; Coleman R; Grundy S M; Peshock R M
Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice.
The American journal of clinical nutrition 1997;65(2):403-8.
1997: Tato F; Vega G L; Grundy S M
Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(1):56-63.
1996: Abate N; Garg A; Peshock R M; Stray-Gundersen J; Adams-Huet B; Grundy S M
Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM.
Diabetes 1996;45(12):1684-93.
1996: Vega G L; Grundy S M
Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease.
Current opinion in lipidology 1996;7(4):209-16.
1996: McPherson R; Grundy S M; Guerra R; Cohen J C
Allelic variation in the gene encoding the cholesteryl ester transfer protein is associated with variation in the plasma concentrations of cholesteryl ester transfer protein.
Journal of lipid research 1996;37(8):1743-8.
1996: Patel S B; Grundy S M
Interactions between microsomal triglyceride transfer protein and apolipoprotein B within the endoplasmic reticulum in a heterologous expression system.
The Journal of biological chemistry 1996;271(31):18686-94.
1996: Grundy S M; Mazzaferri E L
Addressing the spectrum of hypercholesterolemia.
Hospital practice (1995) 1996;31(6):43-8, 53-5, 59; discussion 60.
1996: Martin-Jadraque R; Tato F; Mostaza J M; Vega G L; Grundy S M
Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levels.
Archives of internal medicine 1996;156(10):1081-8.
1996: Fuller C J; Chandalia M; Garg A; Grundy S M; Jialal I
RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus.
The American journal of clinical nutrition 1996;63(5):753-9.
1996: Vega G L; Grundy S M
Hypercholesterolemia with cholesterol-enriched LDL and normal levels of LDL-apolipoprotein B. Effects of the step I diet and bile acid sequestrants on the cholesterol content of LDL.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(4):517-22.
1996: Fuller C J; Grundy S M; Norkus E P; Jialal I
Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
Atherosclerosis 1996;119(2):139-50.
1996: Vega G L; Grundy S M
Quantitation of apolipoprotein B by chemical methods.
Methods in enzymology 1996;263():63-82.
1995: Abate N; Vega G L; Garg A; Grundy S M
Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
Atherosclerosis 1995;118(1):111-22.
1995: Patel S B; Grundy S M
Heterologous expression of apolipoprotein B carboxyl-terminal truncates: a model for the study of lipoprotein biogenesis.
Journal of lipid research 1995;36(10):2090-103.
1995: Abate N; Garg A; Peshock R M; Stray-Gundersen J; Grundy S M
Relationships of generalized and regional adiposity to insulin sensitivity in men.
The Journal of clinical investigation 1995;96(1):88-98.
1995: Tezabwala B U; Bennett M; Grundy S M
Immunotoxicity of polyunsaturated fatty acids in serum-free medium.
Immunopharmacology and immunotoxicology 1995;17(2):365-83.
1995: Tato F; Vega G L; Grundy S M
Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(4):446-51.
1995: Grundy S M
Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy.
The American journal of cardiology 1995;75(6):45B-52B.
1995: Denke M A; Grundy S M
Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
Archives of internal medicine 1995;155(4):393-9.
1995: Vega G L; Toto R D; Grundy S M
Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia.
Kidney international 1995;47(2):579-86.
1994: Cohen J C; Wang Z; Grundy S M; Stoesz M R; Guerra R
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.
The Journal of clinical investigation 1994;94(6):2377-84.
1994: Grundy S M
Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids.
The American journal of clinical nutrition 1994;60(6 Suppl):986S-990S.
1994: Garg A; Grundy S M
Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
Annals of internal medicine 1994;121(6):416-22.
1994: Abate N; Burns D; Peshock R M; Garg A; Grundy S M
Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers.
Journal of lipid research 1994;35(8):1490-6.
1994: Garg A; Bantle J P; Henry R R; Coulston A M; Griver K A; Raatz S K; Brinkley L; Chen Y D; Grundy S M; Huet B A
Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus.
JAMA : the journal of the American Medical Association 1994;271(18):1421-8.
1994: Montali A; Vega G L; Grundy S M
Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(4):511-7.
1994: Denke M A; Grundy S M
Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia.
Archives of internal medicine 1994;154(3):317-25.
1994: Arca M; Vega G L; Grundy S M
Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.
JAMA : the journal of the American Medical Association 1994;271(6):453-9.
1994: Denke M A; Sempos C T; Grundy S M
Excess body weight. An under-recognized contributor to dyslipidemia in white American women.
Archives of internal medicine 1994;154(4):401-10.
1994: Vega G L; Grundy S M
Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia.
Archives of internal medicine 1994;154(1):73-82.
1994: Abbott W G; Tezabwala B; Bennett M; Grundy S M
Melanoma lung metastases and cytolytic effector cells in mice fed antioxidant-balanced corn oil or fish oil diets.
Natural immunity 1994;13(1):15-28.
1993: Jialal I; Grundy S M
Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
Circulation 1993;88(6):2780-6.
1993: Abate N; Vega G L; Grundy S M
Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100.
Atherosclerosis 1993;104(1-2):159-71.
1993: Toto R D; Vega G L; Grundy S M
Mechanisms and treatment of dyslipidemia of renal diseases.
Current opinion in nephrology and hypertension 1993;2(5):784-90.
1993: Blades B; Vega G L; Grundy S M
Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(8):1227-35.
1993: Denke M A; Sempos C T; Grundy S M
Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men.
Archives of internal medicine 1993;153(9):1093-103.
1993: Grundy S M
Oxidized LDL and atherogenesis: relation to risk factors for coronary heart disease.
Clinical cardiology 1993;16(4 Suppl 1):I3-5.
1993: Vega G L; Grundy S M
Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(4):579-89.
1992: Grundy S M
Cholesterol-lowering drugs as cardioprotective agents.
The American journal of cardiology 1992;70(21):27I-32I.
1992: Vega G L; Grundy S M
Occurrence of species of low-density lipoprotein with defective clearance in patients with primary moderate hypercholesterolaemia.
Journal of internal medicine 1992;232(5):405-13.
1992: Cristol L S; Jialal I; Grundy S M
Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers.
Atherosclerosis 1992;97(1):11-20.
1992: Denke M A; Grundy S M
Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins.
The American journal of clinical nutrition 1992;56(5):895-8.
1992: Gylling H; Vega G L; Grundy S M
Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids.
Journal of lipid research 1992;33(10):1527-39.
1992: Garg A; Grundy S M; Unger R H
Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM.
Diabetes 1992;41(10):1278-85.
1992: Jialal I; Grundy S M
Influence of antioxidant vitamins on LDL oxidation.
Annals of the New York Academy of Sciences 1992;669():237-47; discussion 247-8.
1992: Garg A; Fleckenstein J L; Peshock R M; Grundy S M
Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy.
The Journal of clinical endocrinology and metabolism 1992;75(2):358-61.
1992: Wilson M A; Vega G L; Gylling H; Grundy S M
Persistence of abnormalities in metabolism of apolipoproteins B-100 and A-I after weight reduction in patients with primary hypertriglyceridemia.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(8):976-84.
1992: Cohen J C; Grundy S M
Normal postprandial lipemia in men with low plasma HDL concentrations.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(8):972-5.
1992: Bonanome A; Bennett M; Grundy S M
Metabolic effects of dietary stearic acid in mice: changes in the fatty acid composition of triglycerides and phospholipids in various tissues.
Atherosclerosis 1992;94(2-3):119-27.
1992: Jialal I; Grundy S M
Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein.
Journal of lipid research 1992;33(6):899-906.
1992: Grundy S M; Vega G L
Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
Archives of internal medicine 1992;152(1):28-34.
1991: Denke M A; Grundy S M
Effects of fats high in stearic acid on lipid and lipoprotein concentrations in men.
The American journal of clinical nutrition 1991;54(6):1036-40.
1991: Grundy S M
George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(6):1619-35.
1991: Jialal I; Norkus E P; Cristol L; Grundy S M
beta-Carotene inhibits the oxidative modification of low-density lipoprotein.
Biochimica et biophysica acta 1991;1086(1):134-8.
1991: Grundy S M
Hypertriglyceridemia. Examining its role in coronary heart disease.
Postgraduate medicine 1991;90(5):201-2, 207-10.
1991: Vega G L; Grundy S M
Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia.
Journal of internal medicine 1991;230(4):341-50.
1991: Cohen J C; Stray-Gundersen J; Grundy S M
Dissociation between postprandial lipemia and high density lipoprotein cholesterol concentrations in endurance-trained men.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(4):838-43.
1991: Vega G L; Denke M A; Grundy S M
Metabolic basis of primary hypercholesterolemia.
Circulation 1991;84(1):118-28.
1991: Vega G L; Hobbs H H; Grundy S M
Low density lipoprotein kinetics in a family having defective low density lipoprotein receptors in which hypercholesterolemia is suppressed.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(3):578-85.
1991: Jialal I; Freeman D A; Grundy S M
Varying susceptibility of different low density lipoproteins to oxidative modification.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(3):482-8.
1991: Vega G L; Gylling H; Nichols A V; Grundy S M
Evaluation of a method for study of kinetics of autologous apolipoprotein A-I.
Journal of lipid research 1991;32(5):867-75.
1991: Jialal I; Grundy S M
Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
The Journal of clinical investigation 1991;87(2):597-601.
1991: Uauy R; Vega G L; Grundy S M
Coinheritance of two mild defects in low density lipoprotein receptor function produces severe hypercholesterolemia.
The Journal of clinical endocrinology and metabolism 1991;72(1):179-87.
1991: Grundy S M; Vega G L
What is meant by overproduction of apo B-containing lipoproteins?
Advances in experimental medicine and biology 1991;285():213-22.
1990: Grundy S M
Cholesterol and coronary heart disease. Future directions.
JAMA : the journal of the American Medical Association 1990;264(23):3053-9.
1990: Vega G L; Grundy S M
Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy.
JAMA : the journal of the American Medical Association 1990;264(21):2759-63.
1990: Nozaki S; Vega G L; Haddox R J; Dolan E T; Grundy S M
Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
Atherosclerosis 1990;84(2-3):101-10.
1990: Grundy S M
HMG-CoA reductase inhibitors.
Journal of internal medicine 1990;228(3):201-5.
1990: Vega G L; Grundy S M
Does measurement of apolipoprotein B have a place in cholesterol management?
Arteriosclerosis (Dallas, Tex.) 1990;10(5):668-71.
1990: Grundy S M; Vega G L; Garg A
Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemia.
The American journal of cardiology 1990;66(8):31B-38B.
1990: Innerarity T L; Mahley R W; Weisgraber K H; Bersot T P; Krauss R M; Vega G L; Grundy S M; Friedl W; Davignon J; McCarthy B J
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
Journal of lipid research 1990;31(8):1337-49.
1990: Grundy S M; Vega G L
Role of apolipoprotein levels in clinical practice.
Archives of internal medicine 1990;150(8):1579-82.
1990: Grundy S M; Getz G
Aspen Hepatic Cholesterol and Lipoprotein Conference 1989. Report of a conference.
Journal of lipid research 1990;31(7):1327-33.
1990: Grundy S M; Denke M A
Dietary influences on serum lipids and lipoproteins.
Journal of lipid research 1990;31(7):1149-72.
1990: Jialal I; Vega G L; Grundy S M
Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein.
Atherosclerosis 1990;82(3):185-91.
1990: Vega G L; Grundy S M
Management of primary mixed hyperlipidemia with lovastatin.
Archives of internal medicine 1990;150(6):1313-9.
1990: Denke M A; Grundy S M
Hypercholesterolemia in elderly persons: resolving the treatment dilemma.
Annals of internal medicine 1990;112(10):780-92.
1990: Garg A; Bonanome A; Grundy S M; Unger R H; Breslau N A; Pak C Y
Effects of dietary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1990;70(4):1007-13.
1990: Garg A; Grundy S M
Therapeutic perspectives in hyperlipidemic patients with diabetes mellitus.
The Journal of diabetic complications 1990;4(2):72-4.
1990: Faust T W; Redfern J S; Podolsky I; Lee E; Grundy S M; Feldman M
Effects of aspirin on gastric mucosal prostaglandin E2 and F2 alpha content and on gastric mucosal injury in humans receiving fish oil or olive oil.
Gastroenterology 1990;98(3):586-91.
1990: Grundy S M
Management of hyperlipidemia of kidney disease.
Kidney international 1990;37(3):847-53.
1990: Grundy S M; Vega G L
Causes of high blood cholesterol.
Circulation 1990;81(2):412-27.
1990: Vega G L; Krauss R M; Grundy S M
Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins.
Journal of internal medicine 1990;227(2):81-94.
1990: Grundy S M
Drug therapy in dyslipidemia.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1990;199():63-72.
1990: Grundy S M
Cholesterol and coronary heart disease.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1990;199():17-24.
1989: Vega G L; Grundy S M
Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia.
JAMA : the journal of the American Medical Association 1989;262(22):3148-53.
1989: Bonanome A; Grundy S M
Intestinal absorption of stearic acid after consumption of high fat meals in humans.
The Journal of nutrition 1989;119(11):1556-60.
1989: Grundy S M; Vega G L
Rationale and management of hyperlipidemia of the nephrotic syndrome.
The American journal of medicine 1989;87(5N):3N-11N.
1989: Vega G L; Grundy S M
Studies on mechanisms for enhanced clearance of low-density lipoproteins in patients with primary hypertriglyceridaemia.
Journal of internal medicine 1989;226(1):5-15.
1989: Vega G L; Grundy S M
Estimation of turnover of low density lipoproteins by simplified methods.
Atherosclerosis 1989;76(2-3):139-48.
1989: Grundy S M
Monounsaturated fatty acids and cholesterol metabolism: implications for dietary recommendations.
The Journal of nutrition 1989;119(4):529-33.
1989: Vega G L; East C; Grundy S M
Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
Arteriosclerosis (Dallas, Tex.) 1989;9(1 Suppl):I135-44.
1989: Soria L F; Ludwig E H; Clarke H R; Vega G L; Grundy S M; McCarthy B J
Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(2):587-91.
1988: Weisgraber K H; Innerarity T L; Newhouse Y M; Young S G; Arnold K S; Krauss R M; Vega G L; Grundy S M; Mahley R W
Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9758-62.
1988: Garg A; Bonanome A; Grundy S M; Zhang Z J; Unger R H
Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus.
The New England journal of medicine 1988;319(13):829-34.
1988: Uauy R; Vega G L; Grundy S M; Bilheimer D M
Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover.
The Journal of pediatrics 1988;113(2):387-92.
1988: Denke M A; Grundy S M
Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
Hepatology (Baltimore, Md.) 1988;8(4):974-5.
1988: Grundy S M
HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.
The New England journal of medicine 1988;319(1):24-33.
1988: East C; Bilheimer D W; Grundy S M
Combination drug therapy for familial combined hyperlipidemia.
Annals of internal medicine 1988;109(1):25-32.
1988: Grundy S M
Cholesterol education program in the United States.
The Canadian journal of cardiology 1988;4 Suppl A():31A-35A.
1988: Grundy S M
Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
Postgraduate medicine 1988;84(1):217-8, 223-31.
1988: Vega G L; Grundy S M
Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.
Kidney international 1988;33(6):1160-8.
1988: Bonanome A; Grundy S M
Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels.
The New England journal of medicine 1988;318(19):1244-8.
1988: Grundy S M; Vega G L
Hypertriglyceridemia: causes and relation to coronary heart disease.
Seminars in thrombosis and hemostasis 1988;14(2):149-64.
1988: Vega G L; East C; Grundy S M
Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B.
Atherosclerosis 1988;70(1-2):131-43.
1988: Vega G L; Grundy S M
Pathogenesis of hypertriglyceridemia: implications for coronary heart disease and therapy.
Advances in experimental medicine and biology 1988;243():311-26.
1987: Innerarity T L; Weisgraber K H; Arnold K S; Mahley R W; Krauss R M; Vega G L; Grundy S M
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(19):6919-23.
1987: Grundy S M; Kalser S C
Highlights of the meeting on prevention of gallstones.
Hepatology (Baltimore, Md.) 1987;7(5):946-51.
1986: East C; Grundy S M; Bilheimer D W
Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation.
JAMA : the journal of the American Medical Association 1986;256(20):2843-8.
1986: East C A; Grundy S M; Bilheimer D W
Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin.
Metabolism: clinical and experimental 1986;35(2):97-8.
1985: Bilheimer D W; East C; Grundy S M; Nora J J
Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
American journal of medical genetics 1985;22(3):593-8.

Sign-in to see more